Matinas BioPharma Holdings, Inc. (MTNB)
1.701
-0.01
(-0.55%)
USD |
NYAM |
Oct 23, 16:00
1.71
+0.01
(+0.55%)
After-Hours: 20:00
Matinas BioPharma Holdings Price : 1.701 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.71 | 1.78 | 1.69 | 1.701 | 11289.00 |
| Oct 22, 2026 | 1.53 | 1.80 | 1.52 | 1.71 | 48427.00 |
| Oct 21, 2026 | 1.69 | 1.69 | 1.469 | 1.52 | 19906.00 |
| Oct 20, 2026 | 1.66 | 1.72 | 1.51 | 1.70 | 48558.00 |
| Oct 19, 2026 | 2.37 | 2.37 | 1.50 | 1.66 | 273464.0 |
| Oct 16, 2026 | 2.48 | 2.50 | 2.36 | 2.37 | 27337.00 |
| Oct 15, 2026 | 2.44 | 2.54 | 2.42 | 2.42 | 20951.00 |
| Oct 14, 2026 | 2.51 | 2.55 | 2.452 | 2.48 | 19794.00 |
| Oct 13, 2026 | 2.72 | 2.72 | 2.46 | 2.50 | 66365.00 |
| Oct 12, 2026 | 2.85 | 2.85 | 2.70 | 2.74 | 21505.00 |
| Oct 09, 2026 | 2.77 | 2.87 | 2.70 | 2.87 | 40292.00 |
| Oct 08, 2026 | 2.73 | 2.850 | 2.61 | 2.83 | 141883.0 |
| Oct 07, 2026 | 2.99 | 2.99 | 2.63 | 2.77 | 172665.0 |
| Oct 06, 2026 | 2.76 | 3.15 | 2.64 | 3.01 | 417676.0 |
| Oct 05, 2026 | 2.78 | 3.00 | 2.43 | 2.82 | 183966.0 |
| Oct 02, 2026 | 2.53 | 2.748 | 2.421 | 2.64 | 295503.0 |
| Oct 01, 2026 | 2.58 | 2.58 | 2.36 | 2.42 | 45160.00 |
| Sep 30, 2026 | 2.72 | 2.80 | 2.444 | 2.55 | 152603.0 |
| Sep 29, 2026 | 2.47 | 3.050 | 2.40 | 2.88 | 764315.0 |
| Sep 28, 2026 | 2.47 | 2.65 | 2.34 | 2.53 | 117842.0 |
| Sep 25, 2026 | 2.580 | 2.643 | 2.313 | 2.400 | 52014.00 |
| Sep 24, 2026 | 2.625 | 2.685 | 2.568 | 2.670 | 15747.00 |
| Sep 23, 2026 | 2.662 | 2.677 | 2.514 | 2.625 | 28146.00 |
| Sep 22, 2026 | 2.602 | 2.695 | 2.550 | 2.655 | 13723.00 |
| Sep 21, 2026 | 2.400 | 2.623 | 2.400 | 2.608 | 19494.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Price to Book Value | 0.4035 |
| Earnings Yield | -1.06K% |
| Market Cap | 0.7263M |